Jul 3, 2008
By:
Maribel Rios
After a one-year delay in its implementation, the US Pharmacopeia Chapter 467 "Residual Solvents" is now official.
|
Jun 26, 2008
By:
Maribel Rios
Biomedical researchers at UT Southwestern Medical Center and nanotechnology scientists at UT Dallas are collaborating on a study that seeks to selectively kill cancer cells using monoclonal antibodies to coat carbon nanotubes that heat up when exposed to near-infrared (NIR) light.
|
Jun 19, 2008
By:
Maribel Rios
The US Food and Drug Administration and the European Medicines Agency will collaborate in efforts that would allow drug companies to submit results of seven new drug-safety tests.
|
Jun 5, 2008
By:
Maribel Rios
The transatlantic cooperation of the European Commission, the European Medicines Agency, and the US Food and Drug Administration was recognized at the Second Meeting of the Transatlantic Economic Council, held mid May in Brussels. The TEC is tasked with overseeing and accelerating government-to-government cooperation to advance economic integration between the United States and the European Union.
|
Risk management, and its benefits for patients, plays a big role at the PDA Annual Meeting.
Jun 2, 2008
By:
Maribel Rios
Risk management, and its benefits for patients, plays a big role at the PDA Annual Meeting.
|
May 29, 2008
By:
Maribel Rios
University of Calgary biochemists used computer simulation in a new toxicity study to predict how "buckyballs," carbon-60 soccer ball-shaped nanomolecules, could damage animal cells.
|
May 20, 2008
By:
Maribel Rios
The Committee on Oversight and Government Reform held a hearing on whether the US Food and Drug Administration's drug and medical device regulation bar state liability claims.
|
May 15, 2008
By:
Maribel Rios
To establish user fees for the 2009 fiscal year, the US Food and Drug Administration is asking pharmaceutical manufacturers to provide a list of products and finished-dose manufacturing facilities subject to such fees by June 16, 2008.
|
May 8, 2008
By:
Maribel Rios
To keep pace with proposed increases in the number of manufacturing inspections, the US Food and Drug Administration's Office of Regulatory Affairs (ORA) has announced it will increase laboratory capacity and staff.
|
|
